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estrogenic chemicals are widespread environmental contaminants associated with diverse health 
and ecological effects. During early vertebrate development, estrogen receptor signaling is critical for 
many different physiologic responses, including nervous system function. Recently, host-associated 
microbiota have been shown to influence neurodevelopment. Here, we hypothesized that microbiota 
may biotransform exogenous 17-βestradiol (E2) and modify E2 effects on swimming behavior. 
Colonized zebrafish were continuously exposed to non-teratogenic E2 concentrations from 1 to 10 
days post-fertilization (dpf). Changes in microbial composition and predicted metagenomic function 
were evaluated. Locomotor activity was assessed in colonized and axenic (microbe-free) zebrafish 
exposed to E2 using a standard light/dark behavioral assay. Zebrafish tissue was collected for chemistry 
analyses. While E2 exposure did not alter microbial composition or putative function, colonized E2-
exposed larvae showed reduced locomotor activity in the light, in contrast to axenic E2-exposed larvae, 
which exhibited normal behavior. Measured E2 concentrations were significantly higher in axenic 
relative to colonized zebrafish. Integrated peak area for putative sulfonated and glucuronidated E2 
metabolites showed a similar trend. These data demonstrate that E2 locomotor effects in the light 
phase are dependent on the presence of microbiota and suggest that microbiota influence chemical E2 
toxicokinetics. More broadly, this work supports the concept that microbial colonization status may 
influence chemical toxicity.
Essentially all known multicellular organisms are naturally colonized by a diverse array of microbial communi-
ties comprised of bacteria, viruses, archaea, fungi and protozoa. Current estimates suggest that the adult human 
gastrointestinal tract alone harbors more than 100 trillion bacteria from over 1,000 different species1. The metage-
nome of these gut microbiota encodes 100–150 times more genes than the human genome, with rapid plasticity 
and unique biological functions2. Microbiota can interact with their hosts directly or through the production of 
various microbial products, such as extracellular enzymes and cell wall components3 to influence immune and 
nervous systems, metabolism, and behavior4–6. Microbiota can also interact with drugs and environmental chem-
icals in ways that can shift their health effects or toxicity profiles7–9. Such findings indicate that host microbiota 
can be an important determinant of both homeostasis and disease risk.
Neurodevelopmental disorders like autism-spectrum disorder and attention-deficit/hyperactivity disorder 
have increased in prevalence over the last decade10. Emerging evidence indicates that microbiota may mediate 
or influence neurologic development. During early life, different stages of brain development coincide with the 
establishment and development of the gut microbiome11. Recent studies have associated some neurodevelop-
mental disorders with altered microbiota profiles12, and experiments that use axenic (microbe-free) animals or 
antibiotics to deplete host-associated microbiota indicate that microbiota influence key aspects of early neurode-
velopment. Affected processes include formation of the blood-brain barrier13, myelination14, neurogenesis15, neu-
rotransmitter levels16, and behavior17–19. Collectively, these interactions are driven by the microbiota-gut-brain 
axis, which involves bidirectional communication between intestinal microbiota and the central nervous system.
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The increased prevalence of neurodevelopmental disorders also corresponds with increased exposure to 
endocrine disrupting chemicals (EDCs) worldwide20. Endogenous steroid hormones such as 17β-estradiol (E2) 
are critical for nervous system development and mediate endpoints such as neuronal survival, dendritic branching, 
synaptic patterning, and axonal projections21. Increasing concentrations of estrogens in the environment have led to 
widespread public health concerns, especially given the sensitivity of the developing organism to even low micromolar 
or nanomolar concentrations of estrogens22. Recent studies suggest that exposure to estrogenic chemicals 
during sensitive windows of early brain development can disrupt key signaling pathways and result in adverse 
neurological effects23–25. Intestinal microbiota play a significant role in the uptake and metabolism of estrogens26,27. 
Through processes such beta-glucuronidation, gut microbiota can affect chemical enterohepatic circulation and 
excretion and potentially alter endogenous serum estrogen concentrations28–30. However, it is currently unknown 
whether microbiota can interact with exogenous estrogens to mediate neurodevelopmental effects.
Zebrafish are an alternative animal model commonly used in toxicology to examine effects of contaminant 
exposure. More recently, zebrafish have also become an established model for studying host-microbiota inter-
actions19,31,32. Approximately 70% of human protein-coding genes are similar to those in zebrafish and zebrafish 
contain counterparts for 84% of human disease-associated genes33. Advantages of the model include their rapid 
development, small size, transparency, and capability to perform complex motor behaviors. Development of dis-
tinct neural circuits generate the earliest behaviors in zebrafish, which serve as functional readouts of nervous 
system development34. Similar to other vertebrates, zebrafish have complex resident microbial communities with 
a large majority of microbiota concentrated in the intestinal tract35,36. However, zebrafish microbiota are typically 
dominated by Proteobacteria37, while mice and humans contain more Bacteroidetes and Firmicutes35, differences 
that are likely driven by diet, the surrounding environment, and host factors35,38. While microbial composition 
varies across species, more work is needed to understand whether metagenomic function is conserved between 
zebrafish and mammals. Our laboratory and others have recently established methods to generate axenic or col-
onized zebrafish19,39,40, which can be combined with various toxicity assays to evaluate microbiota interactions 
with environmental chemicals.
In this study, we investigated whether microbial colonization status interacts with E2 to influence locomotor 
activity and chemical metabolism in zebrafish. We first characterized the effects of exogenous E2 exposure on 
locomotor activity in colonized zebrafish as a functional measure of nervous system development and investi-
gated changes in host-associated microbial community structure and predicted metagenomic function. We then 
assessed colonization status-dependent changes in locomotor activity using both colonized and axenic zebrafish. 
Finally, we conducted targeted and non-targeted mass spectrometry to measure internal E2 dose and identify 
colonization status-specific metabolite profiles. To our knowledge, this is the first study to demonstrate light 
phase specific locomotor effects that require microbial colonization following exposure to an exogenous chemi-
cal. These findings also show, using a whole organism model, that colonization status influences metabolism of a 
key sex steroid involved in endocrine signaling.
Results
Observed overt toxicity and locomotor effects following developmental exposure to E2. To 
examine whether microbiota can influence behavior or metabolism of E2 during development, we generated con-
ventionally colonized, axenic, or axenic colonized on day 1 larvae19 (Fig. 1). Conventionally colonized zebrafish 
were first exposed continuously in a semi-static system to E2, and survival and morphology were assessed on day 
10 to identify the no observed effect concentration (NOEC) for follow-up studies. By 10 days post-fertilization 
Figure 1. Experimental design. Endpoints assessed on day 10 in larval zebrafish following exposure to 
exogenous E2 on days 1, 6, 7, 8, and 9 are shown. Experiments were conducted in conventionally colonized 
(CC), axenic colonized on day 1 (AC1) and/or axenic (AX; microbe-free) zebrafish cohorts.
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(dpf), all larvae in the 10.2 µM exposure group were abnormal (malformed or severely moribund) or dead, and 
100% mortality was observed in the 30.0 µM exposure group (Fig. 2A). All other treatment groups up to 3.5 µM 
contained ≥92% morphologically normal larvae resulting in a calculated AC50 value (concentration at 50% of 
the maximal effect) of 4.5 µM (Fig. 2A). Locomotor activity was subsequently assessed as a functional measure of 
nervous system development in conventionally colonized larvae exposed to non-teratogenic concentrations of E2. 
Concentration-dependent locomotor hypoactivity was observed in both the light and dark phases (Fig. 2B–D). 
Significant decreases in activity were observed at 0.4, 1.2, and 3.5 µM E2 in the light phase, and at 0.4 and 1.2 µM 
in the dark phase (Fig. 2C,D). At 3.5 µM in the dark, activity was similar to DMSO vehicle controls (Fig. 2D).
E2 exposure does not impact zebrafish-associated microbial communities. To identify whether 
altered behavior following E2 exposure co-occurred with changes in microbial community structure or predicted 
microbial community function, conventionally colonized zebrafish were exposed to five non-teratogenic E2 con-
centrations, and 16S rRNA gene sequencing was used to identify operational taxonomic units (OTUs) present in 
each sample. Non-metric multidimensional scaling (NMDS) analysis revealed that global compositional profiles 
of microbiota did not cluster by E2 treatment (ANOSIM OR = 0.064) (Fig. 3A). Bray-Curtis similarity indices for 
all between-treatment group comparisons (e.g. DMSO vehicle control vs. 0.34 µM E2) were similar and ranged 
on average from 55.8–68.1% (Fig. S1). Taxonomic analysis revealed that Proteobacteria was the most abundant 
phylum at all concentrations tested (data not shown). In addition, 24 bacterial families captured >95.6% of all 
OTUs identified represented, and the relative abundances of family-level taxa were similar across all DMSO con-
trol and E2-exposed larvae (Fig. 3B). E2 exposure also did not impact any alpha diversity metrics including total 
number of species, Margalef ’s species richness index, species evenness, Shannon’s diversity index, or Simpson’s 
diversity (Fig. S2). Relative abundances of PICRUSt-generated Level 2 KEGG predicted functions were similar 
across all treatment groups (Fig. 3C). To assess whether E2-exposure impacted function at a more granular level, 
linear discriminant effect size (LEfSe) analysis was subsequently used to identify differentially abundant Level 3 
KEGG functions (Table S1). All 11 identified functions were not significantly altered in E2-exposed larvae relative 
to DMSO vehicle controls (Fig. S3).
E2-induced locomotor effects in the light phase are dependent on microbiota. To examine 
whether hypoactivity observed in conventionally colonized larvae following E2 exposure (Fig. 2B,C) was related 
to microbial colonization of the host, three cohorts of zebrafish (conventionally colonized, axenic colonized on 
day 1, and axenic)19 (Fig. 1) were continuously exposed to 0.4 or 1.2 µM E2. As expected, DMSO control axenic 
zebrafish were hyperactive in the dark phase relative to conventionally colonized or axenic colonized on day 1 
zebrafish (p < 0.0001, Figs 4A–I and Fig. S4). At 10 dpf, conventionally colonized larvae exhibited significant 
hypoactivity in the light phase at 0.4 and 1.2 µM E2 (p < 0.00001 and p = 0.0407, respectively, Fig. 4B), similar to 
Figure 2. Conventionally colonized zebrafish developmentally exposed to non-teratogenic E2 concentrations 
are hypoactive. (A) Percent abnormal zebrafish larvae are shown. Non-linear regression was performed using 
the log(agonist) vs. normalized response–Variable slope equation in GraphPad Prism. Asterisk indicates 
significant difference from respective DMSO vehicle control group (**p < 0.0001). n = 3 replicate flasks with 15 
larvae per flask. Standard error bars are shown. (B) Movement over 20-minute testing phase and mean distance 
moved in the (C) light or (D) dark period following developmental E2 exposure are shown. White and black 
bars indicate light and dark phases, respectively. n = 23–24 larvae per treatment.
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the initial behavior experiment in conventionally colonized larvae (Fig. 2BC). In the dark phase, significant hypo-
activity was observed at 0.4 µM E2, but not 1.2 µM E2 (p = 0.0043 and p = 0.5862, Fig. 4C). In axenic colonized on 
day 1 larvae, significant hypoactivity was observed in both the light and dark phases at 0.4 and 1.2 µM E2 (light: 
Figure 3. E2 exposure does not impact community structure or predicted function of zebrafish-associated 
microbiota. 16S rRNA gene sequencing was performed on 10 dpf larvae developmentally exposed to E2, and 
PICRUSt was used to predict metagenomic function. Non-metric dimensional scaling (NMDS) ordination 
plots are shown for microbial community structure. The Bray-Curtis similarity index was used to assign 
percent similarity values. Analysis of similarities (ANOSIM) ordered R (OR) statistic is shown. Percent relative 
abundances of (B) family-level taxa or (C) Level 2 KEGG predicted functions in 10 dpf larvae are shown. n = 4 
biological replicates with 10 larvae per replicate.
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p = 0.0033 and p < 0.0001, respectively, dark: p = 0.0259 and p = 0.0004, respectively) (Fig. 4E,F). In contrast 
to colonized larvae, axenic larvae exhibited no significant change in locomotor activity during the light phase 
compared to DMSO vehicle controls (Fig. 4H). In the dark, axenic larvae behaved like colonized larvae exhibiting 
locomotor hypoactivity at 0.4 and 1.2 µM E2 (p = 0.0041 and p = 0.0026, respectively) (Fig. 4I).
Axenic zebrafish contain more parent E2 than colonized zebrafish. To compare measured E2 con-
centrations in exposure media and whole-body tissue homogenates (that included intestinal tracts) obtained 
from conventionally colonized, axenic colonized on day 1, and axenic larvae continuously exposed to 0.4 or 
1.2 µM E2, samples were collected and analyzed using targeted chemistry techniques. Immediately following 
dosing on day 1, measured E2 media concentrations were similar across colonization statuses and ranged from 
0.242–0.453 µM and 0.910–1.485 µM for the 0.4 and 1.2 µM E2 exposure groups, respectively (Dose, p < 0.0001, 
Fig. 5A and Table S2). In day 10 media samples, significant main effects of dose (p < 0.0001) and colonization sta-
tus (p < 0.0001) were observed (Fig. 5B). Average measured media concentrations ranged from 0.155–0.509 µM 
for the 0.4 µM E2 group, and 0.975–1.76 µM for the 1.2 µM E2 group (Fig. 5B and Table S2). Individual doses 
were not compared across colonization status because no significant interaction between dose and colonization 
status was observed. Analysis of day 10 zebrafish tissue revealed distinct colonization-dependent differences in 
measured E2 concentration in zebrafish exposed to 1.2 µM E2. In addition to significant main effects of dose 
(p < 0.0001) and colonization status (p < 0.0001), a significant interaction between these two terms was observed 
(p < 0.0001), indicating that the pattern of measured internal E2 doses across all concentrations tested differed 
by colonization status (Fig. 5C). Subsequent pairwise comparisons revealed that following exposure to a nominal 
concentration of 1.2 µM E2, measured E2 tissue doses in axenic larvae were 2.5–3.7 times higher than in con-
ventionally colonized or axenic colonized on day 1 larvae (Fig. 5C and Table S2). At a nominal concentration of 
0.4 µM E2, tissue doses were comparable across colonization status (Fig. 5C and Table S2).
Axenic zebrafish contain higher abundances of some E2 metabolites. As a hypothesis-generation 
strategy, a non-targeted approach was initially selected to identify any chemical features (e.g. E2 metabolites or 
microbial metabolites) that may be altered in conventionally colonized, axenic colonized on day 1, or axenic 
zebrafish following exposure to 0.4 or 1.2 µM E2. Following initial feature filtering, 94 features were retained 
Figure 4. Locomotor hypoactivity is observed in the light phase in E2-exposed colonized zebrafish only. 
(A,D,G) Movement over 20-minute testing period, (B,E,H) movement over 10 min light phase, or (C,F,I) 
movement over 10 min dark phase are shown. White and black bars indicate light and dark phases, respectively. 
Data for conventionally colonized (A–C), axenic colonized on day 1 (D–F), and axenic (G–I) larvae are shown. 
If a significant 3- or 2-way interaction was observed using a linear mixed effect repeated measures model, 
subsequent Tukey pairwise comparisons were made. Different letters indicate significant differences in the light 
(uppercase) or dark (lowercase) phases (p < 0.05). n = 23–24 larvae per treatment.
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in the dataset (Fig. S5). Comparison of features that met fold-change threshold criteria (≥2-fold) within colo-
nization status (e.g. axenic 0.1% DMSO vs. axenic 1.2 µM E2) yielded numerous significant features in all three 
cohorts (Fig. S6A–C). Between-status comparisons at 1.2 µM E2 (e.g. conventionally colonized 1.2 µM to axenic 
1.2 µM E2) revealed that 33 features were concordant (i.e. increased or decreased) in both conventionally colo-
nized and axenic colonized on day 1 larvae compared to axenic larvae. Of these 33 features, 26 were significantly 
decreased and seven were significantly increased (Fig. S7A–C and Table S3). However, using this stringent fil-
tering approach, only one feature was identified as a predicted E2 metabolite (E2 sulfate) (Fig. 6B), and other 
differentially represented unknown metabolites were not identified. Therefore, to specifically identify additional 
E2 metabolites that were differentially represented following exposure to the parent compound, the raw LC-MS 
data were screened for known metabolites in the E2 metabolism pathway (Fig. 6A). Five chemicals consistent 
with known metabolites were tentatively identified: E2 sulfate, E2 glucuronide (A and B, two isomers), estriol 
(E3) sulfate, estrone (E1) sulfate, and E1 glucuronide (Fig. 6A, Table 1). Integrated peak areas for all metabolites 
were significantly correlated (p < 0.0001) with measured E2 tissue concentrations. The strongest correlations were 
observed for E2 sulfate (r = 0.84) and the two isomers of E2 glucuronide (r = 0.87 and 0.90) (Table 1). Boxplots 
for these E2 metabolites (Fig. 6B–D) show very similar trends to that observed for parent E2 concentrations 
(Fig. 5C). Specifically, peak areas of these metabolites were noticeably elevated in the axenic 1.2 μM E2 group. 
Correlations were less pronounced for E3 sulfate (r = 0.73), E1 sulfate (r = 0.69), and E1 glucuronide (r = 0.69) 
(Table 1), with boxplots showing elevated peak areas across colonization status (Fig. 6E–G).
Figure 5. Axenic zebrafish contain higher concentrations of parent E2. Exposure media and whole zebrafish 
tissue were analyzed by LC-MS/MS. Concentrations of parent E2 in (A) exposure media on day 1, (B) exposure 
media on day 10 or (C) zebrafish tissue on day 10. A concentration of 0 µM refers to 0.1% DMSO vehicle 
controls. Blank (fish-free) flasks contained no zebrafish and were treated like axenic flasks throughout the 
duration of the experiment. If a significant 2-way interaction was observed using multiple linear regression 
models, subsequent pairwise comparisons (Bonferroni correction, p < 0.05) were made. n = 2–5 (10 larvae per 
biological replicate).
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Discussion
Recent work suggests that estrogens and host-associated microbiota, particularly those within the intestinal tract, 
to influence a variety of health outcomes including brain function, behavior, obesity, and cancer28. In this study, 
we used colonized and axenic zebrafish as an experimental system to characterize the effects of E2, a potent estro-
gen receptor agonist, on microbiota composition and predicted metagenomic function. In addition, we asked 
whether E2 exposure impacted locomotor activity in a colonization status-dependent manner. We report that E2 
did not impact microbial community structure or predicted function. However, E2 exposure did result in signif-
icant hypoactivity in the light phase in colonized larvae only. Measured parent E2 concentrations were ~3 times 
higher in axenic relative to colonized zebrafish. Predicted E2 metabolites E2 sulfate and E2 glucuronide were also 
higher in axenic relative to colonized zebrafish. In contrast, E3 sulfate, E1 sulfate and E1 glucuronide were similar 
in colonized and axenic larvae. To our knowledge, this is the first study to demonstrate that microbiota interact 
with an exogenous chemical to influence light phase locomotor effects. Taken together, these data support the 
concept that microbiota and environmental chemicals can interact to influence host physiology.
In mammals, the estrogen signaling pathway has been implicated as an important regulator of various 
cognitive and behavioral responses. For example, low estrogen levels have been associated with a decline in 
memory-related functions in humans and animal models41,42. Similar to the hypoactivity data presented here, 
exposure to E2 in ovariectomized mice resulted in locomotor hypoactivity in a light/dark transition test43. The 
Figure 6. Axenic zebrafish contain higher concentrations of some putative E2 metabolites. LC-MS was 
performed on whole zebrafish tissue. (A) E2 metabolism reference schematic is shown. Black boxes indicate 
putative E2 metabolites identified in this study. Boxplots with integrated peak area for (B) estradiol sulfate, 
(C) estradiol glucuronide A, (D) estradiol glucuronide B, (E) estriol sulfate, (F) estrone sulfate and (G) 
estrone glucuronide in conventionally colonized, axenic colonized on day 1, and axenic larvae are shown. A 
concentration of 0 µM refers to 0.1% DMSO vehicle controls. Spearman rank correlation coefficients were 
calculated to assess the relationships between integrated peak areas for each detected E2 metabolite and 
measured E2 tissue concentrations from targeted analysis (Table 1). n = 2–4 (10 larvae per biological replicate).
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same study also reported increased time spent in the outer zones in an open field test43. These two widely used 
mammalian tests measure anxiety-like behavior, suggesting that, in animals lacking endogenous estrogens, E2 
exposure increased anxiety-like behavior and heightened fear response, both of which are acquired adaptive 
survival behaviors44. In a female rat study, E2 treatment during the neonatal period resulted in improved learning 
and enhanced memory performance in adulthood45. These effects were hypothesized to be related to E2 effects 
on γ-aminobutyric acid (GABA) receptor expression and function in the adult brain45. Together, these studies 
suggest that exogenous E2 exposure has widespread effects on nervous system function in mammalian models.
The circuits that underlie the patterned development of stereotypical locomotor behaviors are highly regu-
lated, and it is now understood that microbiota play a critical role in the development of many normal locomo-
tor phenotypes and regulate neurophysiological behaviors through alteration of neural, endocrine, and immune 
pathways46. We have previously shown that axenic animals lacking microbiota exhibit a consistent increase in 
dark phase locomotor activity19. Using a standard light/dark assay to investigate whether exposure to 0.4 or 1.2 µM 
E2 caused a colonization status-dependent behavioral response, we showed that only colonized larvae exhibited 
light phase locomotor hypoactivity. While both colonized and axenic larvae exhibited locomotor hypoactiv-
ity in the dark phase, these results are consistent with other studies that demonstrate phase-specific behavioral 
effects. For example, in other larval zebrafish studies that used similar light/dark assays, developmental expo-
sure to the flame retardants 2,2′,4,4′-tetrabromodiphenyl ether (BDE-47), tricresyl phosphate (TMPP), and phe-
nol, isopropylated, phosphate (3:1) (IPP) caused dark phase-specific hyper- or hypoactivity47,48. Developmental 
2,2′,4,4′,5-pentabromodiphenyl ether (BDE-99) exposure also resulted in differential phase-specific effects, with 
hyperactivity observed in the light phase and hypoactivity observed in the dark phase47. In addition, Kokel et al. 
showed that embryonic zebrafish exhibit shared and specific behavioral “barcodes” based on their locomotor 
phenotype in response to a photic stimulus over four different phases following exposure to a large-scale set of 
drugs49. This approach allowed for the classification of putative biological mechanisms of action based on barcode 
similarity to pharmacological agents with known modes of action. Collectively, these data show that zebrafish 
light/dark swimming behavior is broadly affected by xenobiotic exposures and that environmental chemicals 
and drugs produce a diverse set of both phase-shared or phase-specific locomotor effects. This evidence further 
suggests that changes in light phase-specific locomotor behavior arise from multiple biological pathway-level 
perturbations. While more work is needed to understand the biology that controls zebrafish swimming behavior 
in response to light or dark stimuli, the data presented here are in line with previous studies that show differential 
phase effects of xenobiotic exposures on locomotor activity47–49. In addition, our results are the first to show that 
changes in the stereotypical locomotor response to a light stimulus following exposure to an exogenous environ-
mental chemical are influenced by microbiota.
Microbiota can interact with environmental chemicals via toxicodynamic (alterations in microbial composi-
tion or function) or toxicokinetic (microbial xenobiotic biotransformations) mechanisms. In this study, due to 
logistical challenges associated with our unique concentration-response design, we did not specifically analyze 
the larval gut microbiome. However, metagenomic analysis revealed that composition of the DMSO vehicle con-
trol zebrafish microbiome in this study was similar to that reported from larval gut microbiomes of 10 dpf fish in 
Stephens et al.37. Specifically, at the phylum and class levels, microbiota obtained from both whole zebrafish larvae 
or larval intestinal tract dissections at 10 dpf was dominated by Proteobacteria and Gammaproteobacteria, and 
contains families that align with core genera identified in adult laboratory and wild zebrafish in Roeselers et al. 
(i.e. Aeromonadaceae, Shewanellaceae, Enterobacteriaceae, and Comamonadaceae)50. These similarities are likely 
because the intestinal tract contains the most bacteria relative to other organs, like in humans36. Some differences 
in composition between microbiota profiles obtained from whole larvae or dissected intestinal tracts were also 
noted. Namely, the Firmicutes phyla comprised on average 4.2% of all bacterial taxa at 10 dpf in Stephens et al. 
In our study, although we did detect Firmicutes (20/232 OTUs), the relative abundance of this phylum was <1% 
of all sample totals. At the family level, higher relative abundances of Chromatiaceae were also observed in our 
study compared with Stephens et al. However, higher levels of Chromatiaceae were not observed in all DMSO 
controls across consecutive experiments done previously in our lab51, suggesting that microbiota variability exists 
within and across aquaculture systems and can be due to a variety of factors including rearing temperature, 
zebrafish strain, and diet35,37,38. Following developmental exposure to five concentrations of E2, global community 
Putative Compound
Neutral 
Mass
Empirical mass-to-
charge ratio (m/z)
Retention 
time (min)
Predicted Molecular 
Formula
Spearman correlation 
coefficienta (p-value)
Estradiol sulfate 352.1344 351.1266 6.4 C18H24O5S
0.84
(<0.0001)
Estradiol glucuronide A 448.2097 447.2019 6.2 C24H32O8
0.87
(<0.0001)
Estradiol glucuronide B 448.2097 447.2019 6.7 C24H32O8
0.90
(<0.0001)
Estriol sulfate 368.1361 367.1283 6.8 C18H24O6S
0.73
(<0.0001)
Estrone sulfate 350.1190 349.1112 6.9 C18H22O5S
0.69
(<0.0001)
Estrone glucuronide 446.1940 445.1862 6.8 C24H30O8
0.69
(<0.0001)
Table 1. Putative estradiol metabolites identified in 10 dpf zebrafish following non-targeted mass spectrometric 
analysis. aCorrelations between peaks areas of putative E2 metabolites and measured E2 tissue concentrations.
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structure and putative function of zebrafish-associated microbiota were not altered. Microbiota are accustomed 
to interacting with endogenous E2 and play a significant role in the uptake and metabolism of estrogens52. 
Therefore, it is plausible that exposure to a key endogenous hormone like E2 does not modify the composition of 
host-associated microbiota in larval zebrafish in the current study. Although one previous study in adult zebraf-
ish using a static-renewal system demonstrated disruption of microbiota following exposure to a nominal con-
centration of 1 µg/l (3.6 nM) E253, these contrasting results are not surprising given that microbial composition 
changes with life stage37.Taken together, the results presented here suggest that toxicokinetic mechanisms (e.g. 
microbial-mediated E2 metabolism) may be driving the E2-induced light phase alterations in locomotor activity.
In the current study, measured internal E2 dose varied depending on colonization status. Paradoxically, 10 
dpf axenic zebrafish contained significantly more (2.5–3.7 times) parent (unconjugated) E2 compared to conven-
tionally colonized or axenic colonized on day 1 larvae. Non-targeted analysis revealed that peak areas of putative 
metabolites E2 sulfate and E2 glucuronide were also elevated in axenic larvae, while peak areas of E3 sulfate, 
E1 sulfate, and E1 glucuronide were similar in colonized and axenic zebrafish. In general, estrogen metabolism 
occurs primarily in the hepatobiliary system and the intestinal “estrobolome” (the bacterial genes that are capable 
of metabolizing estrogens)30, resulting in potential subsequent detoxification or activation. One explanation for 
the observed locomotor phenotype following chemical exposure is that E2 is deconjugated and then converted to 
a more active metabolite, either by microbial enzymes or a more metabolically competent host. Previously pub-
lished work shows that microbiota bioactivate pharmacological agents like diclofenac, indomethacin, ketoprofen, 
and sulfasalazine54,55. As estrogenic activity is often cell, tissue, model, or endpoint-specific, a more bioactive 
estrogen profile could be driven by increased deconjugation and bioavailability56 or metabolites with enhanced 
local ER binding or activation57,58. For example, sulfonated estrogens, particularly E2 sulfate, can circulate in the 
blood and reach estrogen target tissues where they may be deconjugated and converted to receptor-active free 
estrogens59. In addition, a study examining the competitive binding activity of dehydroepiandrosterone (DHEA), 
an abundant steroid hormone that serves as a precursor to estrogen and androgen, and it’s sulfonated metabolite 
(DHEA-S), showed that DHEA-S, but not DHEA, was competitive with E2 for ERɑ and ERβ binding and stimu-
lated MCF-7 cell proliferation60. Parent E2 and E2 glucuronide have also been shown to bind to and activate ERα 
in the liver61. Furthermore, under different physiological conditions, E2 metabolites can differentially activate 
ERɑ and ERβ signaling pathways, elicit downstream gene activation, and trigger intracellular signaling cascades62, 
which may influence neurodevelopment.
Important limitations of the non-targeted approach used in this study included the inability to detect the 
parent compound, unknown differences in extraction efficiency, column affinity, breakdown products, ionization 
efficiency63, and a lack of analytical standards for E2 metabolites. While these limitations precluded direct com-
parisons between levels of E2 metabolites within an exposure group and across colonization statuses, these data 
support the targeted results and suggest that colonization status influences E2 metabolism. In future follow-up 
studies, quantification using a targeted approach would allow for more detailed comparisons of E2 metabolite 
profiles in colonized and axenic zebrafish. It is also possible that E2 metabolites potentially contributing to the 
observed behavioral effect in colonized larvae in the light phase may not have been identified. For instance, we 
did not detect hydroxylated E2 metabolites that have been reported in mammals64. While more work is needed 
to enhance detection and determination of E2 metabolites in zebrafish, the application of non-targeted analysis 
led to the simultaneous identification of five unique sulfonated or glucuronidated E2 metabolites with unknown 
toxicity profiles that may contribute to colonization-specific alterations in locomotor activity. In addition, chemi-
cal toxicokinetics is not simply defined by biotransformation (e.g. bioactivation). As this study did not fully assess 
absorption, distribution, or excretion of E2 in colonized or axenic zebrafish, other potential mechanisms may 
also be related to the novel behavioral phenotype observed in the light phase in colonized larvae described here.
Host-associated microbiota are recognized as important modulators of the complex interactions between 
factors such as diet, sex, race, and life-stage and many human diseases65. An increasing body of evidence suggests 
that microbiota also mediate health effects of xenobiotic exposure including gastrointestinal toxicity and immune 
responses66–69. Our results indicate that microbiota are required for E2-induced light phase locomotor hypoac-
tivity, further supporting the idea that microbiota and chemicals may interact to influence biological processes. 
This work also raises an interesting point related to hazard identification, suggesting that microbiota may be an 
important factor for characterizing chemical interactions with a host organism. Continued investigation of how 
estrogens and other environmental chemicals interact with the microbiota-gut-brain axis may uncover the bio-
logical mechanisms by which microbiota communicate with the nervous system and influence brain development 
and behavior.
Methods
Zebrafish husbandry. All experiments involving zebrafish were approved by the Institutional Animal Care 
and Use Committee at the U.S. EPA National Health and Environmental Effects Research Laboratory and per-
formed in accordance with appropriate guidelines and regulations. A mixed wild type adult zebrafish line (Danio 
rerio) was used for all studies48. Adult zebrafish were housed in 6 L tanks (at a density of ~ 8 fish/l) and fed Gemma 
Micro 300 (Skretting) once daily and shell free E-Z Egg (Brine Shrimp Direct) twice daily during the week. On 
weekends, zebrafish were fed both food sources once daily. Adults were maintained on a 14 h:10 h light:dark cycle 
at 28.5 °C. For spawning, 60–100 adults were placed in 10 L angled static breeding tanks overnight. The following 
morning, adults were transferred to new bottom tanks containing treated reverse osmosis water (60 mg/l sodium 
bicarbonate and 0.4 g/l Crystal Sea Bioassay Formula Marine Mix) and embryos were collected after 45 min.
Chemicals. 17β-estradiol (E2) was purchased from Sigma Aldrich (#E8875, CAS: 50-28-2; Lot: SLBP6339V). 
Stock solution aliquots (40 mM) were prepared by dissolving neat chemical into anhydrous dimethyl sulfoxide 
(DMSO) and stored at −80 °C. For each 10-day experiment, fresh working solutions were prepared by thawing 
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stock solution aliquots and performing serial dilutions in DMSO. Working solutions were stored in 4 ml amber 
glass vials at room temperature. All exposure groups contained a final concentration of 0.1% DMSO (v/v). 
Vehicle controls received 0.1% DMSO only. For targeted chemistry, E2-3,4-13C2 (internal standard, Product#: 
CLM-803-S; Lot#: SDDI-011) was obtained from Cambridge Isotope Laboratories, Inc. (Tewksbury, MA). Stock 
solutions were prepared in methanol and acetonitrile and stored at −20 °C. Intermediate standards were prepared 
fresh daily from stocks. All reagents and solvents were reagent grade or high-performance liquid chromatography 
(HPLC) grade.
exposures. E2 exposures were performed in T25 tissue culture flasks incubated at 26 °C on a 14 h:10 h 
light:dark cycle. Zebrafish were continuously exposed in a semi-static system from 1 to 10 days post-fertilization 
(dpf). For all experiments, chemical exposures began on day 1 (Fig. 1). All flasks were housed statically through 
6 dpf, followed by daily renewal of chemical exposure solutions in concert with an 80% media change (0.2 µm 
filter-sterilized 10% Hanks Balanced Salt Solution (FS-10% HBSS) from 6–9 dpf. On days 6–9, each flask also 
received 75 kGy gamma-irradiated Gemma Micro 75 as a food source at a final concentration of 0.04% (v/v) 
(Fig. 1). Dead embryos or larvae were removed from each flask during media changes. For the developmental tox-
icity experiment, conventionally colonized (CC, colonized with aquaculture facility microbiota on day 0) zebraf-
ish were exposed to 0.05–30 µM E2. These concentrations were selected based on previous zebrafish studies and 
zebrafish assays within the U.S. EPA ToxCast Dashboard (https://actor.epa.gov/dashboard/)25,70,71. For 16S rRNA 
gene sequencing, conventionally colonized zebrafish were exposed to non-teratogenic concentrations ranging 
from 0.34–3.5 µM E2. For 3-cohort behavior and mass spectrometry, conventionally colonized, axenic colonized 
on day 1, and axenic zebrafish were exposed to 0.4 or 1.2 µM E2.
Axenic derivation and conventionalization with fish facility microbiota. Axenic (AX; microbe- 
free) zebrafish were generated as previously described19,39,40 (Fig. 1). Briefly, embryos were resuspended in FS-10% 
HBSS containing antibiotics (amphotericin B (0.25 μg/ml), kanamycin (5 μg/ml) and ampicillin (100 μg/ml)) for 
four hours at 26 °C. At 5 hours post fertilization (hpf), embryos were treated in a 15 ml conical tube with 0.5% 
poly(vinylpyrrolidone)-iodine (PVP-I; CASRN 25655-41-8) for 2 min and 0.05% bleach for 20 min and sorted 
into sterile T25 tissue culture flasks (15–30 embryos per flask, depending on experiment) in 25 ml of FS-10% 
HBSS. As a control for the derivation process, a subset of axenic embryos was conventionalized with aquaculture 
facility microbiota at 1 dpf to generate the axenic colonized on day 1 (AC1) zebrafish cohort. Embryos were 
conventionalized by 80% media change which included 10 ml fish facility water (FRW, fish room water; 5 µm 
syringe-filtered) and 10 ml of FS-10% HBSS (Fig. S8). To maintain consistency between cohorts, axenic and con-
ventionally colonized (colonized on day 0, not treated with antibiotics, PVP-I, or bleach) flasks also underwent 
an 80% media change at 1 dpf. Similar to axenic colonized on day 1 zebrafish, conventionally colonized embryos 
received 10 ml FRW and 10 ml of FS-10% HBSS. Axenic embryos received 10 ml of 0.2 µm filter-sterilized fish 
facility water (FS-FRW) and 10 ml of FS-10% HBSS (Fig. S8).
For experiments involving all three zebrafish cohorts, media sterility was tested as previously described19. 
Briefly, at 1 and 10 dpf, two tryptic soy agar (TSA) plates (Sigma, #22091) were inoculated with 10 µl of media 
from each flask. At 10 dpf, the sterility of media from axenic flasks was further tested by inoculating 100 µL 
of flask media into tubes of Nutrient Broth (Sigma, #70122), Brain Heart Infusion Broth (Sigma, #53286), or 
Sabouraud Dextrose Broth (Sigma, #S3306). Plates and tubes were incubated at 26 °C under aerobic and anaero-
bic conditions for at least seven days. Contaminated flasks were excluded from the study.
Behavior testing. At 10 dpf, morphologically normal larvae were removed from flasks using a sterile transfer 
pipet and placed into 48-well plates containing 500 µl of FS-10% HBSS per well. Plates were sealed with Microseal 
A film (BioRad, #MSA5001), wrapped in Parafilm, and placed in the dark in a temperature controlled behavior 
testing room at 26 °C, for at least 2 hr prior to testing. For testing, microtiter plates were placed on a Noldus 
tracking apparatus and locomotor activity was recorded for 40 mins. The light program consisted of a 20-min 
acclimation period in the dark (0 lux) followed by a 10 min light period (5 lux) and a 10 min dark period (0 lux). 
All tests were carried out between 11:15 am–4:00 pm. Videos were analyzed using Ethovision software Version 12 
(Noldus Information Technology) as described previously48.
DNA sequencing of 16S rRNA gene. Whole-body zebrafish homogenates were used to evaluate changes 
in microbial community structure and predicted function. DNA extraction and sequencing of the 16S rRNA 
gene was completed as previously described19. Briefly, 10 dpf larvae (n = 4 biological replicates, 10 larvae per rep-
licate) were collected, anesthetized, and homogenized. DNA was isolated from each sample using a ZR-Duet™ 
DNA/RNA MiniPrep Kit (Zymo Research #D7003). Total DNA yield was quantified and samples were stored at 
−80 °C. DNA (250 ng) from each sample was added to triplicate PCR reactions along with barcoded primers72  
specific for the V4 region of the 16S rRNA gene and amplified with the Roche FastStart High Fidelity PCR 
System (Sigma-Aldrich, #4738292001). PCR reactions were run at 95 °C for 2 min, followed by 25 cycles of 95 °C 
for 30 sec, 55 °C for 30 sec and 72 °C for 1 min, with a 10 min final extension at 72 °C. Triplicate reactions were 
pooled and products were purified and normalized with the SequalPrep Normalization Plate Kit (ThermoFisher, 
#A1051001). Samples were pooled by volume and DNA was sequenced using the Illumina MiSeq Reagent Kit v2 
(500 cycles, #MS-102-2003) and Illumina MiSeq instrument. Positive and negative PCR control reactions were 
run with every 30 samples19.
Analysis of 16S rRNA gene sequences. For microbial community structure and predicted metagenomic 
function analyses, paired-end sequences were trimmed at a length of 250 base pairs and quality filtered at <0.5% 
expected error using USEARCH v773. Reads were analyzed using the QIIME 1.9.0 software package74,75. The 
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total number of reads for each sample can be found in Table S4. A cutoff of 500 reads per sample was used for 
downstream analyses. One sample did not meet this criterion (3.5 µM E2_R4). A closed-reference OTU table was 
generated within QIIME-1.9.0 and used to assess microbial composition and generate PICRUSt (Phylogenetic 
Investigation of Communities by Reconstruction of Unobserved States) functional predictions76 with the 
Greengenes 13_8 reference database (https://catalog.data.gov). Alpha and beta diversity analyses were performed 
using PRIMER 7 software (Primer-E v7.0.11) for total number of species, Margalef ’s richness index, Pielou’s 
evenness index, Simpson’s index, Shannon’s diversity index, Bray-Curtis similarities, and non-metric multidimen-
sional scaling (NMDS) ordination plots as previously described19. Stacked bar plots were generated using OTUs 
or predicted functions that contributed at least 1% to any of the sample totals. The KEGG orthology classification 
scheme was used for functional annotations77 and relative abundances of predicted functional pathways were for-
matted as previously described78. Kruskal-Wallis and pairwise Wilcoxon tests were conducted (ɑ = 0.05) using E2 
as the main categorical variable. Linear Discriminant Analysis (LDA) scores >2.0 were used to assess functional 
enrichment. Microbial community structure was also analyzed with mothur-generated OTU tables and the Silva 
reference database as previously described19,79 and provided for future reference as a taxonomic record (Table S5).
sample generation and preparation for mass spectrometry. Conventionally colonized, axenic col-
onized on day 1 and axenic zebrafish larvae were exposed to 0.1% DMSO or 0.4 or 1.2 µM E2 as described above. 
Blank (fish-free) flasks containing gamma-irradiated Gemma Micro 75 only were included as a control. On day 
1, 1 ml of media was collected from all flasks immediately after dosing to measure initial E2 concentrations. At 10 
dpf, larvae were transferred from each flask to a vial containing a final volume of 500 µl FS-10% HBSS (n = 2–5 
biological replicates, 10 larvae per replicate). Larvae were anesthetized on ice, flash frozen in liquid nitrogen, and 
stored at −80 °C. Media samples (1 ml) from each flask were also collected at 10 dpf and stored at −80 °C. Larval 
tissue samples were homogenized in 200 µl of 0.1% formic acid in acetonitrile containing the E2-3,4-13C2 internal 
standard using a FastPrep 24 homogenizer (MP Biomedicals, Santa Ana, CA) and ~150 mg, 1.0 mm diameter 
zirconia/silica beads. The homogenate was centrifuged at 14,000 rpm for 15 minutes at 4 °C. For analysis, 150 µl 
of the supernatant was diluted in a liquid chromatography (LC) vial with 150 µl of HPLC grade water. Exposure 
media was prepared for analysis by diluting 200 µl with 50 µl methanol containing the E2-3,4-13C2 internal stand-
ard. Calibration and verification standards were prepared in solvent: 0.1% formic acid in 50% acetonitrile and 
water for zebrafish tissue samples and 20% methanol in water for exposure media samples. Blanks and quality 
control samples were prepared by adding appropriate amounts of tissue homogenate or exposure media.
targeted mass spectrometry and analysis. Targeted chemistry analysis was conducted by liquid 
chromatography-tandem mass spectrometry (LC-MS/MS) on an Accela UPLC and TSQ Quantum Ultra triple 
quadrupole mass spectrometer (Thermo Fisher Scientific, Waltham, MA) equipped with atmospheric pressure 
photo ionization (APPI) source with krypton lamp operated in positive ionization mode. LC separation was 
achieved using Kinetex EVO, 50 × 2.1 mm, C18, 2.6 µm, 100 å LC column (Phenomenex, Torrance, CA) with 
gradient elution at a flow rate of 360 µl/min using A (5% methanol and water) and B (5% water and methanol). 
Initial LC conditions, 80% A and 20% B, were held for 15 seconds followed by a linear ramp to 100% B at 8 min-
utes, and held at 100% B for 2 minutes. The column was equilibrated for 2 minutes at initial conditions. Total 
run time was 12 minutes. Toluene was added to the LC flow post column at 40 µl/min using a PHD Ultra syringe 
pump (Harvard Apparatus, Holliston, Massachusetts). Source conditions were optimized for the precursor 
[M-H2O + H]+ ions of E2. Collision energy and collision pressure were optimized for product ions of E2 and 
E2-(3,4-13C2).
Integration, calibration, and quantitation were performed using Xcalibur 3.0.63 (Thermo Fisher Scientific). 
The observed measured range in zebrafish tissue was 486 fmole/larva - 15 picomole/larva with a 56 fmole/larva 
method detection limit (MDL). Recovery of 80% was observed for samples spiked at 1.9 pmol/larva and matrix 
effects were observed to be less than 10%. The observed range in exposure media was 45.9 nM - 2.31 µM with a 
4 nM MDL. 86% recovery was observed for samples spiked at 459 nM and matrix effects were observed to be less 
than 10%. Batch results were accepted based on the following criteria: 1) The six standard calibration curve had 
a correlation coefficient >0.99 and accuracy tolerance ≤20%, 2) >75% of all individual quality control standards 
had sample accuracy tolerance ≤30% and %RSD (precision) ≤20%, and 3) blank response was < MDL.
Non-targeted mass spectrometry and analysis. To identify endogenous and xenobiotic metabolites 
associated with E2 exposure and microbial status, non-targeted mass spectrometric analysis was performed 
within a four-week period on the same samples used for targeted mass spectrometry. Sample extract (10 µl) was 
injected in triplicate. Analyte separation was accomplished using Waters Acquity UPLC® BEH C18 (2.1 × 50 mm, 
1.7 µm) connected to an Agilent 1290 Infinity II Liquid Chromatography system (Palo Alto, CA) equipped with 
a degasser, binary pump, and autosampler. The mobile phase flow rate for gradient elution was set at 200 µl/min 
using A (aqueous 0.1% formic acid) and B (acetonitrile with 0.1% formic acid). The gradient started with 90% 
A and 10% B for 2 min, followed by a linear ramp to 100% B after 15 min. This condition was kept for 5 min 
before returning to starting mobile phase conditions at 21 min. The column was re-equilibrated for the next 
injection for 9 min. Total run time was 30 min. An Agilent 6530B Accurate-Mass Quadrupole Time-of-Flight 
Mass Spectrometer (Palo Alto, CA) with a Dual AJS ESI source was operated under positive and negative electro-
spray ionization in full scan mode (100–1000 m/z). The following spray settings were employed: capillary voltage 
(±3500 V), nozzle voltage (500 V), fragmentor (135 au), skimmer (65 au), octupole RF peak (750 au), gas temper-
ature (300 °C), gas flow (1 L/min), nebulizer pressure (40 psig), sheath gas temperature (350 °C), and sheath gas 
flow (11 L/min). Data were acquired under 2 GHz extended dynamic range mode.
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Raw data were initially processed using Agilent Profinder vendor software (v.8.00) for molecular feature 
extraction and integration, with additional filtering using in-house scripts (Supplemental Methods). Chemical 
features (unique empirical mass-to-charge ratio (m/z) and retention time (min)) were tentatively assigned based 
on hits against the EPA Chemistry Dashboard (https://comptox.epa.gov/dashboard/) and an Agilent Personal 
Compound Database and Library (PCDL) of the METLIN database80. Monoisotopic ion masses for components 
of the E2 metabolism pathway (see Fig. 6A) were then separately extracted for each data file using a 10 ppm mass 
window. The extracted ion chromatograms were smoothed with a 9-point moving average and integrated with 
Agilent’s Agile 2 algorithm. For samples which lacked an obvious peak, a time window corresponding to the aver-
age peak window was manually integrated to capture a noise value. If a sample showed no chromatographic noise 
at the elution time, the value was recorded as zero.
statistical analyses. The AC50 value for E2 (i.e. concentration that elicits a 50% inhibitory response) was 
obtained from the zebrafish developmental toxicity assay using the log(agonist) vs. normalized response–Variable 
slope equation (GraphPad Prism 7)71. A one-way analysis of variance (ANOVA) with Tukey pairwise compar-
isons was used for analysis of the zebrafish developmental toxicity assay. An analysis of similarities (ANOSIM) 
test (concentration = ordered factor) was used to assess changes in microbial composition. For comparisons of 
Bray-Curtis similarity scores, a permutational one-way analysis of variance PERMANOVA with pairwise Monte 
Carlo comparisons was used (p < 0.05). Alpha diversity metrics were analyzed using a Kruskal-Wallis and Dunn’s 
pairwise multiple comparisons test (p < 0.05). All behavior data were analyzed using SAS v9.4 software using a 
mixed effects repeated measures model. Each individual fish was used as a subject for the repeated measures, with 
the movement measures across phase (10 min light or 10 min dark period) and time (five time points within each 
phase, reflecting each two min period). Plate, flask and experiment effects were tested as random factors, found 
to be not significant (ɑ = 0.05), and subsequently removed from the model. Main effects of each fixed factor (i.e. 
concentration, phase, or time), and any interaction between or among the factors, were tested within each status. 
Backwards stepwise elimination was used to identify the most parsimonious model. If a significant 3-way inter-
action (concentration*phase*time, p < 0.05) or 2-way interaction (concentration*phase, p < 0.05) was observed, 
differences between concentration groups were tested in each phase using t-tests with a Tukey-Kramer adjust-
ment for multiple comparisons.
For targeted chemistry data analysis, multiple linear regression models were used to identify significant pre-
dictors of E2 tissue concentration (pmole/larva) or E2 exposure media concentration (µM). Backwards stepwise 
elimination was used to identify the most parsimonious model using square root-adjusted values to satisfy mod-
eling assumptions related to normality and homoscedasticity. The effects of concentration, status, or interaction 
on zebrafish tissue or exposure media concentrations or abundance were assessed (p < 0.05). For zebrafish tissue, 
any negative values (five non-detects, only found in DMSO controls) were assigned the lowest non-negative 
value (0.0003 pmol/larva) in the dataset. If a significant interaction between dose and status was observed, pair-
wise comparisons across groups were evaluated using differences of least squares means and Bonferroni-adjusted 
p-values (p < 0.05). For non-targeted chemistry analysis, Spearman rank correlation coefficients were calculated 
to assess the relationships between integrated peak areas for each detected E2 metabolite and measured E2 tissue 
concentrations from targeted analysis.
Data Availability
The datasets generated during the current study are available by searching for the manuscript title at https://
catalog.data.gov.
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